Investing

Options Prospectus

Cardiex Limited (ASX:CDX) (Cardiex, the Company) is pleased to share its Options Prospectus.

This Prospectus is being issued for an offer of up to 27,000,000 Quoted Options exercisable at $0.20 each and expiring at 5:00pm (AEST) on 30 November 2025 (Quoted Options) comprising of the following offers:

1. an offer of up to 25,000,000 Quoted Options to C2 Ventures Pty Limited; and

2. up to 2,000,000 Quoted Options to Directors, Mr Charles Taylor and Mr Randall King Nelson (or their nominees); (together, the Offer).

The Offer under this Prospectus closes at 5.00pm (AEST) on 25 June 2024.*

Click here for the full ASX Release

This post appeared first on investingnews.com

You may also like

Melodiol Q2 Revenue and Updates

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it ...